Jungmi Chae

Dr. Jungmi Chae

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
YNYunha Noh
Yunha Noh
HLHyesung Lee
Hyesung Lee
ACAhhyung Choi
Ahhyung Choi
JKJun Soo Kwon
Jun Soo Kwon
SCSeung-Ah Choe
Seung-Ah Choe
JSJu-Young Shin
Ju-Young Shin
Background: Benzodiazepines are frequently prescribed during pregnancy; however, evidence about possible teratogenicity is equivocal. We aimed to evaluate the association between first-trimester benzodiazepine use and the risk of major congenital malformations.Methods and findings: Using Korea’s nationwide healthcare database, we conducted a population-based cohort study of women who gave birth during 2011 to 2018 and their live-born infants. The exposure was defined as one or more benzodiazepine prescriptions during the first trimester. We determined the relative risks (RRs) and confidence intervals (CIs) of overall congenital malformations and 12 types of organ-specific malformations. Infants were followed from birth to death or 31 December 2019, whichever came first (up to 8 years of age). Propensity score fine stratification was employed to control for 45 potential confounders. Among a total of 3,094,227 pregnancies, 40,846 (1.3%) were exposed to benzodiazepines during the first trimester (mean [SD] age, 32.4 [4.1] years). The absolute risk of overall malformations was 65.3 per 1,000 pregnancies exposed to benzodiazepines versus 51.4 per 1,000 unexposed pregnancies. The adjusted RR was 1.09 (95% CI 1.05 to 1.13,p< 0.001) for overall malformations and 1.15 (1.10 to 1.21,p< 0.001) for heart defects. Based on mean daily lorazepam-equivalent doses, the adjusted RRs for overall malformations and heart defects were 1.05 (0.99 to 1.12,p= 0.077) and 1.12 (1.04 to 1.21,p= 0.004) for <1 mg/day and 1.26 (1.17 to 1.36,p< 0.001) and 1.31 (1.19 to 1.45,p< 0.001) for >2.5 mg/day doses, respectively, suggesting a dose–response relationship. A small but significant increase in risk for overall and heart defects was detected with several specific agents (range of adjusted RRs: 1.08 to 2.43). The findings were robust across all sensitivity analyses, and negative control analyses revealed a null association. Study limitations include possible exposure misclassification, residual confounding, and restriction to live births.Conclusions: In this large nationwide cohort study, we found that first-trimester benzodiazepine exposure was associated with a small increased risk of overall malformations and heart defects, particularly at the higher daily dose. The absolute risks and population attributable fractions were modest. The benefits of benzodiazepines for their major indications must be considered despite the potential risks; if their use is necessary, the lowest effective dosage should be prescribed to minimize the risk.Trial registration: ClinicalTrials.gov NCT04856436.

1 January 2021 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JCJungmi Chae
Jungmi Chae
YCYeonmi Choi
Yeonmi Choi
SCSu-Jin Cho
Su-Jin Cho
Chae J, et al. Yonsei Med J. 2021 Dec;62(12):1155-1161. https://doi.org/10.3349/ymj.2021.62.12.1155

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BKBongyoung Kim
Bongyoung Kim
SASong Vogue Ahn
Song Vogue Ahn
DKDong-Sook Kim
Dong-Sook Kim
JCJungmi Chae
Jungmi Chae
SJSu Jin Jeong
Su Jin Jeong
JCJun Yong Choi
Jun Yong Choi
Kim B, et al. J Korean Med Sci. 2022 Jun;37(24):e191. https://doi.org/10.3346/jkms.2022.37.e191

1 January 2024 in Infection & Chemotherapy
Verified
Journal Article
Open access
IYI Ji Yun
I Ji Yun
HPHyo Jung Park
Hyo Jung Park
JCJungmi Chae
Jungmi Chae
SHSeok Jae Heo
Seok Jae Heo
YKYong Chan Kim
Yong Chan Kim
JCJun Yong Choi
Jun Yong Choi
Yun IJ, et al. Infect Chemother. 2024 Jun;56:e26. https://doi.org/10.3947/ic.2024.0013

31 May 2022 in Health Insurance Review & Assessment Service Research
Verified
Journal Article
Open access
PDF file
YLYoseb Lee
Yoseb Lee
JKJeong Lim Kim
Jeong Lim Kim
SKSo Hee Kim
So Hee Kim
JCJungmi Chae
Jungmi Chae
Yoseb Lee, Jeong Lim Kim, So Hee Kim, Jungmi Chae. HIRA Research 2022;2:106-19. https://doi.org/10.52937/hira.22.2.1.106

21 June 2023 in Infection & Chemotherapy
Verified
Journal Article
Open access
YKYujeong Kim
Yujeong Kim
JCJungmi Chae
Jungmi Chae
SSSeohee Shin
Seohee Shin
GJGayoung Jo
Gayoung Jo
JSJihye Shin
Jihye Shin
JLJin Yong Lee
Jin Yong Lee
Kim Y, et al. Infect Chemother. 2023 Jun;55:e32. https://doi.org/10.3947/ic.2023.0028